J
Jagmeet P. Singh
Researcher at Harvard University
Publications - 405
Citations - 13812
Jagmeet P. Singh is an academic researcher from Harvard University. The author has contributed to research in topics: Cardiac resynchronization therapy & Heart failure. The author has an hindex of 50, co-authored 378 publications receiving 11386 citations. Previous affiliations of Jagmeet P. Singh include University of Rochester Medical Center & The Commonwealth Medical College.
Papers
More filters
Journal ArticleDOI
Real-World Assessment of Acute Left Ventricular Lead Implant Success and Complication Rates: Results from the Attain Success Clinical Trial.
John D. Hummel,Mark A Coppess,Jeffrey S. Osborn,Raymond Yee,Jeffrey W.H. Fung,Ralph Augostini,Shelby Li,Douglas S. Hine,Jagmeet P. Singh +8 more
TL;DR: The Attain Success study was a prospective nonrandomized multicenter global study with the main objectives of assessing single‐system LVL implant success and complication rates.
Journal ArticleDOI
Electrocardiographic optimization techniques in resynchronization therapy
Margarida Pujol-López,Rodolfo San Antonio,Lluís Mont,Emilce Trucco,José María Tolosana,Elena Arbelo,Eduard Guasch,Edwin Kevin Heist,Jagmeet P. Singh +8 more
TL;DR: Electrocardiographic optimization methods available: 12-lead electrocardiogram; fusion-optimized intervals (FOI); intracardiac electrogram-based algorithms; and electrocardsiographic imaging are described.
Journal ArticleDOI
The cost of non-response to cardiac resynchronization therapy: characterizing heart failure events following cardiac resynchronization therapy.
Niraj Varma,Angelo Auricchio,Allison T. Connolly,John P. Boehmer,Marwan Bahu,Maria Rosa Costanzo,Fabio Leonelli,Dale Yoo,Jagmeet P. Singh,Yelena Nabutovsky,Michael R. Gold +10 more
TL;DR: In this paper, the authors quantify healthcare resource utilization among non-responders to cardiac resynchronization therapy (CRT-NR) by heart failure (HF) events and influence of comorbidities.
Journal ArticleDOI
Current immunotherapy in gastrointestinal malignancies A Review.
TL;DR: The role of immunotherapy in the treatment of GI cancers has also been discussed in this paper, particularly in patients with advanced metastatic disease or malignancies refractory to initial treatment.
Journal ArticleDOI
A novel method for determining the phase of T-wave alternans: diagnostic and therapeutic implications.
Omid Sayadi,Faisal M. Merchant,Dheeraj Puppala,Theofanie Mela,Jagmeet P. Singh,E. Kevin Heist,Chris Owen,Antonis A. Armoundas +7 more
TL;DR: In this paper, the signed derivative of the T-wave integral sequence (SDE) was used to identify the phase of TWA in artificially induced alternans and to suppress spontaneous TWA during acute ischemia.